Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping - PAST Extension

Clinical trial NCT04937959 · UNKNOWN

Trial details

NCT number: NCT04937959
Sponsor: Novoic Limited
Status: UNKNOWN
Study type: OBSERVATIONAL

Alzheimer Disease Alzheimer's Disease (Incl Subtypes)Preclinical Alzheimer's Disease Prodromal Alzheimer's Disease Mild Cognitive Impairment Normal Cognition

Start date: 2021-01-22
Primary completion: 2022-08-30
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.